TreeWAS – Variant ID: rs1324183

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K76 Other diseases of liver	0.000	0.733	0.267
K76.8 Other specified diseases of liver	0.000	0.734	0.266
K76.9 Liver disease, unspecified	0.000	0.747	0.253
K76.6 Portal hypertension	0.000	0.750	0.250
K70-K77 Diseases of liver	0.000	0.781	0.219
K70 Alcoholic liver disease	0.000	0.781	0.219
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.791	0.209
K70.3 Alcoholic cirrhosis of liver	0.000	0.798	0.202
K76.1 Chronic passive congestion of liver	0.000	0.798	0.202
K70.9 Alcoholic liver disease, unspecified	0.000	0.803	0.197
K70.0 Alcoholic fatty liver	0.000	0.806	0.194
K76.3 Infarction of liver	0.000	0.807	0.193
K76.5 Hepatic veno-occlusive disease	0.000	0.809	0.191
K76.4 Peliosis hepatis	0.000	0.809	0.191
K76.2 Central haemorrhagic necrosis of liver	0.000	0.809	0.191
K72 Hepatic failure, not elsewhere classified	0.000	0.811	0.189
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.836	0.164
K70.1 Alcoholic hepatitis	0.000	0.837	0.163
K77 Liver disorders in diseases classified elsewhere	0.000	0.837	0.163
K71 Toxic liver disease	0.000	0.845	0.155
K72.9 Hepatic failure, unspecified	0.000	0.845	0.155
K76.7 Hepatorenal syndrome	0.000	0.848	0.152
K72.0 Acute and subacute hepatic failure	0.000	0.849	0.151
K70.4 Alcoholic hepatic failure	0.000	0.853	0.147
K73 Chronic hepatitis, not elsewhere classified	0.000	0.857	0.143
K72.1 Chronic hepatic failure	0.000	0.859	0.141
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.878	0.122
K71.0 Toxic liver disease with cholestasis	0.000	0.881	0.119
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.883	0.117
K71.8 Toxic liver disease with other disorders of liver	0.000	0.888	0.111
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.888	0.111
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.888	0.111
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.888	0.111
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.888	0.111
K71.2 Toxic liver disease with acute hepatitis	0.000	0.888	0.111
K73.9 Chronic hepatitis, unspecified	0.000	0.888	0.111
K71.9 Toxic liver disease, unspecified	0.000	0.889	0.110
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.890	0.110
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.896	0.103
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.897	0.103
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.897	0.103
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.908	0.092
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.911	0.089
K74 Fibrosis and cirrhosis of liver	0.000	0.916	0.084
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.075	0.925	0.000
K75 Other inflammatory liver diseases	0.000	0.929	0.071
K74.5 Biliary cirrhosis, unspecified	0.000	0.935	0.065
Z91.6 Personal history of other physical trauma	0.000	0.935	0.065
K74.3 Primary biliary cirrhosis	0.000	0.936	0.064
K74.4 Secondary biliary cirrhosis	0.000	0.939	0.061
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.939	0.061
K74.1 Hepatic sclerosis	0.000	0.941	0.059
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.944	0.056
K75.2 Nonspecific reactive hepatitis	0.000	0.949	0.051
K75.1 Phlebitis of portal vein	0.000	0.949	0.051
K75.8 Other specified inflammatory liver diseases	0.000	0.954	0.046
K75.0 Abscess of liver	0.000	0.959	0.041
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.036	0.964	0.000
K75.4 Autoimmune hepatitis	0.000	0.965	0.035
T39.1 4-Aminophenol derivatives	0.000	0.967	0.033
T39.0 Salicylates	0.000	0.968	0.032
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.968	0.032
K75.9 Inflammatory liver disease, unspecified	0.000	0.969	0.031
K74.0 Hepatic fibrosis	0.001	0.970	0.029
K74.6 Other and unspecified cirrhosis of liver	0.000	0.973	0.027
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.026	0.974	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.026	0.974	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.026	0.974	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.026	0.974	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.026	0.974	0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.026	0.974	0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.026	0.974	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.026	0.974	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.975	0.025
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.025	0.975	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.976	0.024
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.976	0.024
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.977	0.023
T39.4 Antirheumatics, not elsewhere classified	0.000	0.977	0.023
T39.2 Pyrazolone derivatives	0.000	0.977	0.023
F31.0 Bipolar affective disorder, current episode hypomanic	0.023	0.977	0.000
F31 Bipolar affective disorder	0.023	0.977	0.000
F31.9 Bipolar affective disorder, unspecified	0.023	0.977	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.978	0.022
T40.4 Other synthetic narcotics	0.000	0.978	0.022
T43.2 Other and unspecified antidepressants	0.000	0.979	0.021
T36 Poisoning by systemic antibiotics	0.000	0.979	0.021
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.021	0.979	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.980	0.020
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.980	0.020
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.980	0.020
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.019	0.981	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.981	0.019
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.981	0.019
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.982	0.018
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.982	0.018
T40.3 Methadone	0.000	0.982	0.018
T40.5 Cocaine	0.000	0.982	0.018
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.982	0.018
T40.6 Other and unspecified narcotics	0.000	0.982	0.018
T42.4 Benzodiazepines	0.000	0.982	0.018
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.982	0.018
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.018	0.982	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.017	0.983	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.983	0.017
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.983	0.017
T40.8 Lysergide [LSD]	0.000	0.983	0.017
T40.7 Cannabis (derivatives)	0.000	0.983	0.017
T40.0 Opium	0.000	0.983	0.017
T43.9 Psychotropic drug, unspecified	0.000	0.983	0.017
T36.3 Macrolides	0.000	0.983	0.017
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.983	0.017
F31.7 Bipolar affective disorder, currently in remission	0.017	0.983	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.017	0.983	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.983	0.017
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.983	0.017
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.984	0.016
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.984	0.016
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.984	0.016
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.984	0.016
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.984	0.016
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.984	0.016
T40.1 Heroin	0.000	0.984	0.016
T42.3 Barbiturates	0.000	0.984	0.016
T36.4 Tetracyclines	0.000	0.985	0.015
T36.8 Other systemic antibiotics	0.000	0.985	0.015
T36.9 Systemic antibiotic, unspecified	0.000	0.985	0.015
T36.7 Antifungal antibiotics, systemically used	0.000	0.985	0.015
T36.6 Rifamycins	0.000	0.985	0.015
T36.5 Aminoglycosides	0.000	0.985	0.015
T36.2 Chloramphenicol group	0.000	0.985	0.015
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.985	0.015
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.985	0.015
F31.8 Other bipolar affective disorders	0.015	0.985	0.000
T48.5 Anti-common-cold drugs	0.000	0.985	0.015
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.985	0.014
T48.4 Expectorants	0.000	0.985	0.014
T48.3 Antitussives	0.000	0.985	0.014
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.985	0.014
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.985	0.014
T48.0 Oxytocic drugs	0.000	0.985	0.014
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.985	0.014
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.985	0.014
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.985	0.014
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.985	0.014
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.985	0.014
T44.0 Anticholinesterase agents	0.000	0.985	0.014
T36.0 Penicillins	0.000	0.985	0.014
T38.0 Glucocorticoids and synthetic analogues	0.000	0.985	0.014
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.985	0.014
T42.2 Succinimides and oxazolidinediones	0.000	0.985	0.014
T38.1 Thyroid hormones and substitutes	0.000	0.986	0.014
T47.0 Histamine H(2)-receptor antagonists	0.000	0.986	0.014
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.014	0.986	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.986	0.014
T42.0 Hydantoin derivatives	0.000	0.986	0.014
T47.2 Stimulant laxatives	0.000	0.986	0.014
T38.9 Other and unspecified hormone antagonists	0.000	0.986	0.014
T38.7 Androgens and anabolic congeners	0.000	0.986	0.014
T38.4 Oral contraceptives	0.000	0.986	0.014
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.986	0.014
T38.2 Antithyroid drugs	0.000	0.986	0.014
T47.6 Antidiarrhoeal drugs	0.000	0.986	0.014
T40.2 Other opioids	0.000	0.986	0.014
T38.5 Other oestrogens and progestogens	0.000	0.986	0.014
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.986	0.013
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.986	0.014
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.986	0.013
T46.7 Peripheral vasodilators	0.000	0.986	0.013
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.986	0.014
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.986	0.013
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.986	0.013
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.986	0.013
T47.7 Emetics	0.000	0.986	0.013
T47.5 Digestants	0.000	0.986	0.013
T47.3 Saline and osmotic laxatives	0.000	0.986	0.013
T49.9 Topical agent, unspecified	0.000	0.986	0.013
T49.8 Other topical agents	0.000	0.986	0.013
T49.7 Dental drugs, topically applied	0.000	0.986	0.013
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.986	0.013
T49.5 Ophthalmological drugs and preparations	0.000	0.986	0.013
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.986	0.013
T49.3 Emollients, demulcents and protectants	0.000	0.986	0.013
T49.2 Local astringents and local detergents	0.000	0.986	0.013
T49.1 Antipruritics	0.000	0.986	0.013
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.987	0.013
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.987	0.013
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.987	0.013
T41.5 Therapeutic gases	0.000	0.987	0.013
T41.4 Anaesthetic, unspecified	0.000	0.987	0.013
T41.3 Local anaesthetics	0.000	0.987	0.013
T41.1 Intravenous anaesthetics	0.000	0.987	0.013
T41.0 Inhaled anaesthetics	0.000	0.987	0.013
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.987	0.013
T41.2 Other and unspecified general anaesthetics	0.000	0.987	0.013
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.987	0.013
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.987	0.013
T47.4 Other laxatives	0.000	0.987	0.013
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.987	0.012
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.988	0.012
M72 Fibroblastic disorders	0.012	0.988	0.000
T50.1 Loop [high-ceiling] diuretics	0.000	0.988	0.012
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.988	0.012
T50.7 Analeptics and opioid receptor antagonists	0.000	0.988	0.012
T50.5 Appetite depressants	0.000	0.988	0.012
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.988	0.012
T50.0 Mineralocorticoids and their antagonists	0.000	0.988	0.012
T43.6 Psychostimulants with abuse potential	0.000	0.988	0.012
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.988	0.012
T37.5 Antiviral drugs	0.000	0.988	0.012
T37.4 Anthelminthics	0.000	0.988	0.012
T37.3 Other antiprotozoal drugs	0.000	0.988	0.012
T37.1 Antimycobacterial drugs	0.000	0.988	0.012
T37.0 Sulphonamides	0.000	0.988	0.012
T42.1 Iminostilbenes	0.000	0.988	0.012
T50.8 Diagnostic agents	0.000	0.988	0.012
T46.1 Calcium-channel blockers	0.000	0.988	0.012
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.988	0.012
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.988	0.011
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.988	0.011
T50.4 Drugs affecting uric acid metabolism	0.000	0.989	0.011
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.989	0.011
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.989	0.011
Z04.9 Examination and observation for unspecified reason	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.989	0.010
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.990	0.010
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.010	0.990	0.000
M72.1 Knuckle pads	0.009	0.991	0.000
M72.5 Fasciitis, not elsewhere classified	0.009	0.991	0.000
M72.8 Other fibroblastic disorders	0.009	0.991	0.000
M72.6 Necrotizing fasciitis	0.009	0.991	0.000
M72.4 Pseudosarcomatous fibromatosis	0.009	0.991	0.000
M72.3 Nodular fasciitis	0.009	0.991	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.991	0.009
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.991	0.009
N88.8 Other specified noninflammatory disorders of cervix uteri	0.009	0.991	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.991	0.008
T45.8 Other primarily systemic and haematological agents	0.000	0.991	0.008
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.991	0.008
T45.6 Fibrinolysis-affecting drugs	0.000	0.991	0.008
T45.3 Enzymes, not elsewhere classified	0.000	0.991	0.008
Z73.9 Problem related to life-management difficulty, unspecified	0.000	0.991	0.009
M72.9 Fibroblastic disorder, unspecified	0.008	0.992	0.000
T45.4 Iron and its compounds	0.000	0.992	0.008
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.992	0.008
M72.2 Plantar fascial fibromatosis	0.008	0.992	0.000
Z73.3 Stress, not elsewhere classified	0.000	0.992	0.008
Z73 Problems related to life-management difficulty	0.000	0.993	0.007
T45.5 Anticoagulants	0.000	0.993	0.007
T45.2 Vitamins, not elsewhere classified	0.000	0.993	0.007
M72.14 Knuckle pads (Hand)	0.007	0.993	0.000
M72.19 Knuckle pads (Site unspecified)	0.007	0.993	0.000
M72.18 Knuckle pads-Other	0.007	0.993	0.000
M72.17 Knuckle pads (Ankle and foot)	0.007	0.993	0.000
M72.16 Knuckle pads-Lower Leg	0.007	0.993	0.000
M72.15 Knuckle pads-Pelvic/Thigh	0.007	0.993	0.000
M72.13 Knuckle pads-Forearm	0.007	0.993	0.000
M72.12 Knuckle pads-Upper arm	0.007	0.993	0.000
M72.11 Knuckle pads-Shldr region	0.007	0.993	0.000
M72.10 Knuckle pads (Multiple sites)	0.007	0.993	0.000
Z96.8 Presence of other specified functional implants	0.000	0.993	0.007
M72.53 Fasciitis, not elsewhere classified-Forearm	0.007	0.993	0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.007	0.993	0.000
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.007	0.993	0.000
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.007	0.993	0.000
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.007	0.993	0.000
M72.54 Fasciitis, not elsewhere classified-Hand	0.007	0.993	0.000
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.007	0.993	0.000
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.007	0.993	0.000
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.007	0.993	0.000
M72.39 Nodular fasciitis-Site unspec	0.006	0.993	0.000
M72.38 Nodular fasciitis-Other	0.006	0.993	0.000
M72.37 Nodular fasciitis-Ankle/Foot	0.006	0.993	0.000
M72.36 Nodular fasciitis-Lower Leg	0.006	0.993	0.000
M72.35 Nodular fasciitis-Pelvic/Thigh	0.006	0.993	0.000
M72.34 Nodular fasciitis-Hand	0.006	0.993	0.000
M72.33 Nodular fasciitis-Forearm	0.006	0.993	0.000
M72.32 Nodular fasciitis-Upper arm	0.006	0.993	0.000
M72.31 Nodular fasciitis-Shldr region	0.006	0.993	0.000
M72.30 Nodular fasciitis-Mult sites	0.006	0.993	0.000
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.006	0.993	0.000
M72.48 Pseudosarcomatous fibromatosis (Other)	0.006	0.993	0.000
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.006	0.993	0.000
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.006	0.993	0.000
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.006	0.993	0.000
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.006	0.993	0.000
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.006	0.993	0.000
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.006	0.993	0.000
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.006	0.993	0.000
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.006	0.993	0.000
M72.69 Necrotizing fasciitis (Site unspecified)	0.006	0.993	0.000
M72.68 Necrotizing fasciitis (Other)	0.006	0.993	0.000
M72.67 Necrotizing fasciitis (Ankle and foot)	0.006	0.993	0.000
M72.66 Necrotizing fasciitis (Lower leg)	0.006	0.993	0.000
M72.65 Necrotizing fasciitis (Pelvic region and thigh)	0.006	0.993	0.000
M72.64 Necrotizing fasciitis (Hand)	0.006	0.993	0.000
M72.63 Necrotizing fasciitis (Forearm)	0.006	0.993	0.000
M72.62 Necrotizing fasciitis (Upper arm)	0.006	0.993	0.000
M72.61 Necrotizing fasciitis (Shoulder region)	0.006	0.993	0.000
M72.60 Necrotizing fasciitis (Multiple sites)	0.006	0.993	0.000
M72.89 Other fibroblastic disorders (Site unspecified)	0.006	0.993	0.000
M72.88 Other fibroblastic disorders (Other)	0.006	0.993	0.000
M72.87 Other fibroblastic disorders (Ankle and foot)	0.006	0.993	0.000
M72.86 Other fibroblastic disorders (Lower leg)	0.006	0.993	0.000
M72.85 Other fibroblastic disorders (Pelvic region and thigh)	0.006	0.993	0.000
M72.84 Other fibroblastic disorders (Hand)	0.006	0.993	0.000
M72.83 Other fibroblastic disorders (Forearm)	0.006	0.993	0.000
M72.82 Other fibroblastic disorders (Upper arm)	0.006	0.993	0.000
M72.81 Other fibroblastic disorders (Shoulder region)	0.006	0.993	0.000
M72.80 Other fibroblastic disorders (Multiple sites)	0.006	0.993	0.000
M72.58 Fasciitis, not elsewhere classified-Other	0.006	0.993	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.993	0.006
M72.99 Fibroblastic disorder, unspecified (Site unspecified)	0.006	0.994	0.000
M72.98 Fibroblastic disorder, unspecified (Other)	0.006	0.994	0.000
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)	0.006	0.994	0.000
M72.96 Fibroblastic disorder, unspecified (Lower leg)	0.006	0.994	0.000
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)	0.006	0.994	0.000
M72.93 Fibroblastic disorder, unspecified (Forearm)	0.006	0.994	0.000
M72.92 Fibroblastic disorder, unspecified (Upper arm)	0.006	0.994	0.000
M72.91 Fibroblastic disorder, unspecified (Shoulder region)	0.006	0.994	0.000
M72.90 Fibroblastic disorder, unspecified (Multiple sites)	0.006	0.994	0.000
Z73.8 Other problems related to life-management difficulty	0.000	0.994	0.006
B91 Sequelae of poliomyelitis	0.000	0.994	0.006
M72.28 Plantar fascial fibromatosis-Other	0.006	0.994	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.006	0.994	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.006	0.994	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.006	0.994	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.006	0.994	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.006	0.994	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.006	0.994	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.006	0.994	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.006	0.994	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.006	0.994	0.000
Z73.5 Social role conflict, not elsewhere classified	0.000	0.994	0.005
Z73.4 Inadequate social skills, not elsewhere classified	0.000	0.994	0.005
Z73.2 Lack of relaxation and leisure	0.000	0.994	0.005
Z73.1 Accentuation of personality traits	0.000	0.994	0.005
Z73.0 Burn-out	0.000	0.994	0.005
M72.94 Fibroblastic disorder, unspecified (Hand)	0.005	0.994	0.000
Z73.6 Limitation of activities due to disability	0.000	0.995	0.005
S83.2 Tear of meniscus, current	0.000	0.995	0.005
N02.8 Other	0.000	0.995	0.005
Z36.8 Other antenatal screening	0.005	0.995	0.000
Z36 Antenatal screening	0.005	0.995	0.000
S83.6 Sprain and strain of other and unspecified parts of knee	0.000	0.995	0.005
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.005	0.995	0.000
Z13.9 Special screening examination, unspecified	0.005	0.995	0.000
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.000	0.995	0.005
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.004	0.996	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.996	0.004
F30-F39 Mood [affective] disorders	0.004	0.996	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.996	0.004
Z36.1 Antenatal screening for raised alphafetoprotein level	0.004	0.996	0.000
F30 Manic episode	0.004	0.996	0.000
S81.9 Open wound of lower leg, part unspecified	0.000	0.996	0.004
Z36.2 Other antenatal screening based on amniocentesis	0.004	0.996	0.000
S22.20 Fracture of sternum (closed)	0.004	0.996	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.996	0.004
Z22.5 Carrier of viral hepatitis	0.000	0.996	0.004
Z36.0 Antenatal screening for chromosomal anomalies	0.004	0.996	0.000
M13.00 Polyarthritis, unspecified (Multiple sites)	0.000	0.996	0.004
Z36.5 Antenatal screening for isoimmunisation	0.004	0.996	0.000
Q66.8 Other congenital deformities of feet	0.004	0.996	0.000
F30.9 Manic episode, unspecified	0.004	0.996	0.000
S22.2 Fracture of sternum	0.004	0.996	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.996	0.004
G44.2 Tension-type headache	0.004	0.996	0.000
F38 Other mood [affective] disorders	0.004	0.996	0.000
C67.2 Lateral wall of bladder	0.000	0.996	0.004
S81.0 Open wound of knee	0.000	0.996	0.004
S22 Fracture of rib(s), sternum and thoracic spine	0.004	0.996	0.000
E14.3 With ophthalmic complications	0.000	0.996	0.004
S83.1 Dislocation of knee	0.000	0.996	0.003
F30.0 Hypomania	0.003	0.996	0.000
S22.40 Multiple fractures of ribs (closed)	0.004	0.996	0.000
S83.4 Sprain and strain involving (fibular)(tibial) collateral ligamnent of knee	0.000	0.996	0.003
S22.4 Multiple fractures of ribs	0.003	0.996	0.000
N88 Other noninflammatory disorders of cervix uteri	0.004	0.996	0.000
S83.3 Tear of articular cartilage of knee, current	0.000	0.996	0.003
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.997	0.003
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.000	0.997	0.003
F30.1 Mania without psychotic symptoms	0.003	0.997	0.000
S83.0 Dislocation of patella	0.000	0.997	0.003
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.000	0.997	0.003
F30.2 Mania with psychotic symptoms	0.003	0.997	0.000
S81 Open wound of lower leg	0.000	0.997	0.003
F30.8 Other manic episodes	0.003	0.997	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.997	0.003
F34 Persistent mood [affective] disorders	0.003	0.997	0.000
Q05.9 Spina bifida, unspecified	0.003	0.997	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.997	0.003
B90-B94 Sequelae of infectious and parasitic diseases	0.000	0.997	0.003
S22.5 Flail chest	0.003	0.997	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.997	0.003
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.997	0.003
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.997	0.003
G44.4 Drug-induced headache, not elsewhere classified	0.003	0.997	0.000
F39 Unspecified mood [affective] disorder	0.003	0.997	0.000
G44 Other headache syndromes	0.003	0.997	0.000
F38.0 Other single mood [affective] disorders	0.003	0.997	0.000
F38.8 Other specified mood [affective] disorders	0.003	0.997	0.000
S83.7 Injury to multiple structures of knee	0.000	0.997	0.003
B02.9 Zoster without complication	0.003	0.997	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.000	0.997	0.003
S22.21 Fracture of sternum (open)	0.003	0.997	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.003	0.997	0.000
N88.0 Leukoplakia of cervix uteri	0.003	0.997	0.000
O72.0 Third-stage haemorrhage	0.003	0.997	0.000
N02 Recurrent and persistent haematuria	0.000	0.997	0.003
F38.1 Other recurrent mood [affective] disorders	0.003	0.997	0.000
S22.1 Multiple fractures of thoracic spine	0.003	0.997	0.000
S20.2 Contusion of thorax	0.003	0.997	0.000
S22.50 Flail chest (closed)	0.003	0.997	0.000
S22.9 Fracture of bony thorax, part unspecified	0.003	0.997	0.000
S22.8 Fracture of other parts of bony thorax	0.003	0.997	0.000
G44.3 Chronic posttraumatic headache	0.003	0.997	0.000
S22.3 Fracture of rib	0.003	0.997	0.000
B94 Sequelae of other and unspecified infectious and parasitic diseases	0.000	0.997	0.003
S29.9 Unspecified injury of thorax	0.003	0.997	0.000
S22.41 Multiple fractures of ribs (open)	0.003	0.997	0.000
G44.8 Other specified headache syndromes	0.003	0.997	0.000
N88.2 Stricture and stenosis of cervix uteri	0.003	0.997	0.000
Z04.1 Examination and observation following transport accident	0.003	0.997	0.000
S81.7 Multiple open wounds of lower leg	0.000	0.997	0.003
S29 Other and unspecified injuries of thorax	0.003	0.997	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
F34.0 Cyclothymia	0.003	0.997	0.000
J93.9 Pneumothorax, unspecified	0.003	0.997	0.000
S20 Superficial injury of thorax	0.003	0.997	0.000
S20-S29 Injuries to the thorax	0.003	0.997	0.000
B94.8 Sequelae of other specified infectious and parasitic diseases	0.000	0.997	0.003
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.003	0.997	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.000	0.997	0.003
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.000	0.997	0.002
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.997	0.003
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.003	0.997	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.003	0.997	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.997	0.003
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
F34.9 Persistent mood [affective] disorder, unspecified	0.002	0.997	0.000
F34.8 Other persistent mood [affective] disorders	0.002	0.997	0.000
N88.3 Incompetence of cervix uteri	0.002	0.997	0.000
G44.1 Vascular headache, not elsewhere classified	0.002	0.997	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.997	0.002
G44.0 Cluster headache syndrome	0.003	0.997	0.000
B90 Sequelae of tuberculosis	0.000	0.997	0.002
B92 Sequelae of leprosy	0.000	0.997	0.002
S22.51 Flail chest (open)	0.002	0.997	0.000
G54.0 Brachial plexus disorders	0.003	0.997	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.997	0.003
O63.0 Prolonged first stage (of labour)	0.003	0.997	0.000
S22.0 Fracture of thoracic vertebra	0.002	0.997	0.000
M62.8 Other specified disorders of muscle	0.000	0.997	0.003
O90.8 Other complications of the puerperium, not elsewhere classified	0.002	0.997	0.000
S20.3 Other superficial injuries of front wall of thorax	0.002	0.997	0.000
Z76.9 Persons encountering health services in unspecified circumstances	0.000	0.997	0.002
N88.1 Old laceration of cervix uteri	0.002	0.998	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.998	0.002
S80-S89 Injuries to the knee and lower leg	0.000	0.998	0.002
J93.1 Other spontaneous pneumothorax	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.000	0.998	0.002
S22.10 Multiple fractures of thoracic spine (closed)	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
N02.6 Dense deposit disease	0.000	0.998	0.002
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.998	0.002
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.998	0.002
S22.11 Multiple fractures of thoracic spine (open)	0.002	0.998	0.000
C67.5 Bladder neck	0.000	0.998	0.002
F34.1 Dysthymia	0.002	0.998	0.000
H93.1 Tinnitus	0.000	0.998	0.002
Z04.3 Examination and observation following other accident	0.000	0.998	0.002
M62.88 Other specified disorders of muscle (Other)	0.000	0.998	0.002
M62.82 Other specified disorders of muscle (Upper arm)	0.000	0.998	0.002
S22.81 Fracture of other parts of bony thorax (open)	0.002	0.998	0.000
S22.80 Fracture of other parts of bony thorax (closed)	0.002	0.998	0.000
S22.91 Fracture of bony thorax, part unspecified (open)	0.002	0.998	0.000
S22.90 Fracture of bony thorax, part unspecified (closed)	0.002	0.998	0.000
S86 Injury of muscle and tendon at lower leg level	0.000	0.998	0.002
Z04 Examination and observation for other reasons	0.002	0.998	0.000
S22.31 Fracture of rib (open)	0.002	0.998	0.000
B94.2 Sequelae of viral hepatitis	0.000	0.998	0.002
B94.1 Sequelae of viral encephalitis	0.000	0.998	0.002
B94.0 Sequelae of trachoma	0.000	0.998	0.002
N02.1 Focal and segmental glomerular lesions	0.000	0.998	0.002
N00-N08 Glomerular diseases	0.000	0.998	0.002
C67.1 Dome of bladder	0.000	0.998	0.002
S20.1 Other and unspecified superficial injuries of breast	0.002	0.998	0.000
J93 Pneumothorax	0.002	0.998	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.998	0.002
Z76 Persons encountering health services in other circumstances	0.000	0.998	0.002
Z91 Personal history of risk-factors, not elsewhere classified	0.000	0.998	0.002
Z70-Z76 Persons encountering health services in other circumstances	0.000	0.998	0.002
S20.0 Contusion of breast	0.002	0.998	0.000
Z75.0 Medical services not available in home	0.000	0.998	0.002
S22.30 Fracture of rib (closed)	0.002	0.998	0.000
G81.9 Hemiplegia, unspecified	0.002	0.998	0.000
S29.0 Injury of muscle and tendon at thorax level	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations